1. Home
  2. IMRN vs DLPN Comparison

IMRN vs DLPN Comparison

Compare IMRN & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • DLPN
  • Stock Information
  • Founded
  • IMRN 1994
  • DLPN N/A
  • Country
  • IMRN Australia
  • DLPN United States
  • Employees
  • IMRN N/A
  • DLPN N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • DLPN Other Consumer Services
  • Sector
  • IMRN Health Care
  • DLPN Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • DLPN Nasdaq
  • Market Cap
  • IMRN 15.0M
  • DLPN 12.9M
  • IPO Year
  • IMRN N/A
  • DLPN N/A
  • Fundamental
  • Price
  • IMRN $1.96
  • DLPN $1.07
  • Analyst Decision
  • IMRN Strong Buy
  • DLPN Strong Buy
  • Analyst Count
  • IMRN 1
  • DLPN 1
  • Target Price
  • IMRN $5.00
  • DLPN $5.00
  • AVG Volume (30 Days)
  • IMRN 6.0K
  • DLPN 42.6K
  • Earning Date
  • IMRN 12-31-2024
  • DLPN 11-14-2024
  • Dividend Yield
  • IMRN N/A
  • DLPN N/A
  • EPS Growth
  • IMRN N/A
  • DLPN N/A
  • EPS
  • IMRN N/A
  • DLPN N/A
  • Revenue
  • IMRN $3,271,194.00
  • DLPN $51,389,626.00
  • Revenue This Year
  • IMRN N/A
  • DLPN $21.74
  • Revenue Next Year
  • IMRN N/A
  • DLPN $7.26
  • P/E Ratio
  • IMRN N/A
  • DLPN N/A
  • Revenue Growth
  • IMRN 171.67
  • DLPN 21.66
  • 52 Week Low
  • IMRN $1.59
  • DLPN $0.95
  • 52 Week High
  • IMRN $5.96
  • DLPN $3.58
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 45.89
  • DLPN 42.93
  • Support Level
  • IMRN $2.05
  • DLPN $1.02
  • Resistance Level
  • IMRN $2.23
  • DLPN $1.15
  • Average True Range (ATR)
  • IMRN 0.17
  • DLPN 0.09
  • MACD
  • IMRN -0.00
  • DLPN -0.01
  • Stochastic Oscillator
  • IMRN 29.69
  • DLPN 17.14

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: